Brief: BRAIN Biotech Completes 10% Cash Capital Increase
Sept 16 (Reuters) - BRAIN Biotech AG BNNn.DE :
* SAID ON WEDNESDAY IT HAS SUCCESSFULLY COMPLETED 10% CASH
CAPITAL
INCREASE FROM AUTHORISED CAPITAL WITH EXCLUSION OF STATUTORY
SUBSCRIPTION RIGHTS
* EUR 19 MLN RAISED WITH AN ISSUE PRICE OF EUR 9.85 PER NEW
SHARE
Source text for Eikon: ID:nEQ6sr1s0a
Further company coverage: BNNn.DE
(Gdansk Newsroom)
((Gdansk.Newsroom@thomsonreuters.com;))
Recent news on BRAIN Biotech AG
See all newsBrief: BRAIN Biotech 9M EBITDA EUR -1.6 Million
CEOs Lukas Linnig And Michael Krohn To Leave Co
Brief: Brain Biotech Signs Exclusive Pharma Licensing Agreement With Akribion For Up To EUR 92.3 Million Milestone Fees Plus Royalties
Brief: BRAIN Biotech 9M Adj. EBITDA at EUR -1.2 Million
Europe Research Roundup: AB Foods, Bunzl, Barratt